US 12,414,960 B2Granted

Analogues of oleuropein and oleacein and uses thereof

AssigneeAttica Sciences Ltd.

InventorDimitrios Iliopoulos

Life of this patent

Estimating the term…

Abstract

Analogues of oleuropein and oleacein and pharmaceutically acceptable salts thereof and processes for the preparation of these compounds are disclosed. The invention further relates to use of oleuropein and oleacein analogues for the treatment of inflammatory disorders, cardiometabolic disorders, and cancer.

Claims32

Dependent claims

A compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 17/500,099Filed 13 Oct 2021 · us provisional application
Priority: 13 Oct 2020
Published: US 2022/0110962 A114 Apr 2022
Granted: 16 Sep 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification20 codes

A61K 31/7048
Compounds having saccharide radicals and heterocyclic rings: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin,…
A61K 31/22
Of carboxylic acids: of acyclic acids, e.g. pravastatin
A61K 31/222
Of acyclic acids, e.g. pravastatin: with compounds having aromatic groups, e.g. dipivefrine, ibopamine
A61K 31/265
Esters, e.g. nitroglycerine, selenocyanates: of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid,…

Family

Application63/091,059Us provisional application · filed 13 Oct 2020
US 2022/0110962 A1Pre-grant publication · published 14 Apr 2022
US 12,414,960 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results